Stock Spotlight Archives - Page 194 of 388

MondayMay 17, 2021 11:44 am

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Continues Building Brand Visibility in Cryptocurrency Space

ISW Holdings (OTC: ISWH), a global brand management holdings company with commercial operations in telehealth and cryptocurrency mining, was featured in a recent article as one of four leaders among crypto stocks (https://ibn.fm/DX9r0). The article discussed expected continued momentum of the cryptocurrency space based on the views of Cathie Wood, a stock picker who has gained global attention in the past two years for her success. The article noted ISWH’s upcoming keynote address and two additional panel appearances at this summer’s Mining Disrupt conference to be held in Miami. As an elite sponsor, ISW Holdings will also have a prominent…

FridayMay 14, 2021 3:03 pm

QualityStocksNewsBreaks – Infobird Co. Ltd.’s (NASDAQ: IFBD) New SaaS Model Designed to Expand Customer Base, Capture More Market Share

Infobird (NASDAQ: IFBD), a leading artificial intelligence (“AI”) software-as-a-service (“SaaS”) provider is positioned for opportunity amid a wave of digital transformation sweeping across China. In the last two decades, the company has gleaned tremendous experience and achieved significant technological advances and service capabilities while providing customized SaaS products to some of China’s largest and most demanding financial institutions. With that solid foundation in place, Infobird recently implemented a strategic transition to standardized module SaaS with the intent to expand its customer base and quickly capture additional market share. “Standardized module SaaS has the characteristics of fast scale up and low…

FridayMay 14, 2021 1:39 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Latest Acquisition Brings in Innovative Team of Experts

Healthtech Solutions (OTC: HLTT), focused on acquiring and investing in strategic cutting-edge health care technological opportunities, is among biotech players that have pivoted to a new model wherein multiple portfolio companies operate under one parent organization. Healthtech’s latest acquisition, Varian Biopharmaceuticals, brings to three the number of subsidiaries under its umbrella. “The acquisition of Varian by Healthtech plays to the strengths of the new portfolio model not only in drug pipeline but also by bringing in experts in an area that could attract additional investment,” reads a recent article. A precision oncology company, Varian specializes in developing atypical protein kinase…

FridayMay 14, 2021 1:33 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Focuses ‘Covid-ID Lab’ Commercialization Strategy Initially on German Market

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently entered a strategic distribution, storage and logistics agreement for its commercial 25-minute COVID-19 RT-PCR test system (“Covid-ID Lab”). In April, XPhyto announced its entry into the agreement with a full-fledged German pharmaceutical wholesaler and service provider. Under the agreement, the German partner will distribute, store and deliver Covid-ID Lab test kits to XPhyto’s customers in line with product specifications and relevant logistical and regulatory requirements in Germany. A recent article quotes XPhyto CEO and Director Hugh Rogers, who noted that the company had secured a strong partner…

FridayMay 14, 2021 1:02 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Radically Different Cultivation Approach

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) has sought to differentiate itself by focusing on a genetics-based cultivation approach that enables production of premium-quality strains and products. This focus is influenced by the company’s resolution to avoid the fate that has befallen its competitors that have seen recent declines in market share. According to a recent article, PACR’s genetics-based cultivation approach has allowed it “to produce 50 super-elite strains and roughly 350 tested cultivars, which in turn has resulted in the company maximizing yields, boosting profitability and minimizing labor costs. In fact, as Pac Roots CEO explained, the company’s…

FridayMay 14, 2021 12:37 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Collaborating to Potentially Uncover Innovative New Treatment Options

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, recently began a collaboration with JelikaLite in a clinical trial. The clinical trial, which has 30 participants from two New York City locations, is designed to potentially uncover new treatment options to reduce autism symptoms in children. “JelikaLite was launched by medical researchers and practitioners specializing in psychology, neurology and phototherapy. The company has developed an innovative solution to potentially reduce autism symptoms and is developing a home-based system that combines a therapeutic wearable device called Cognilum(TM) with an AI-personalized platform. . . Cognilum delivers treatments…

ThursdayMay 13, 2021 2:53 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Is ‘America’s Critical Mineral Hub’

Energy Fuels (NYSE American: UUUU) (TSX: EFR) was featured in a recent article discussing its emergence as “America’s Critical Mineral Hub,” and a leader in the domestic production of uranium, vanadium and rare earth elements (“REEs”). These critical minerals are the building blocks of many clean energy technologies, including electric vehicles (“EVs”), renewable energy systems, nuclear energy and advanced grid-scale batteries. UUUU is the largest U.S. producer of uranium, a leading producer of vanadium and has launched a new fully integrated REE supply chain for the United States and Europe. Energy Fuels president and CEO Mark Chalmers was quoted in…

ThursdayMay 13, 2021 12:55 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) to Offer ‘Brief Insights into Human Nature Itself’

FingerMotion (OTCQX: FNGR) has leveraged its relationship with the three largest telecommunication companies in China and has, as a result, grown its big data division. “This division comprises a team of data scientists and actuaries who have developed proprietary algorithms to predict human behavior,” reads a recent article. FNGR then tests and refines these algorithms using platforms provided by the telecommunication juggernauts, which have a combined subscriber base of over 1.5 million users. “FingerMotion, which intends to ultimately offer products for the insurance, health care and finance sectors, is initially focusing on insurtech. This focus was evident in January when…

ThursdayMay 13, 2021 12:28 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Keen on Becoming Nation’s Largest, Most Profitable Uranium Company

Uranium Energy (NYSE American: UEC) is intent on advancing and expanding Burke Hollow’s resources, an in-situ recovery (“ISR”) uranium project in South Texas, according to a recent article. As a result, it “restarted wellfield development and resource delineation drilling.” The expansion of Burke Hollow’s resources “dovetails with UEC’s plans to participate in supplying the U.S. Uranium Reserve (‘UR’) as outlined in the Nuclear Fuel Working Group report published by the U.S. Department of Energy.” The company controls the largest uranium resource base of fully permitted ISR projects in Texas and Wyoming of any U.S.-based producer and is also “investing to…

ThursdayMay 13, 2021 11:52 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Collaborates to Potentially Develop New Therapy for Treatment-Resistant Psychiatric Disorders

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently acquired Adelia Therapeutics, thereby adding CYB003 to its pipeline. It subsequently made an equally important move when it inked a drug-development agreement with Catalent Inc. (NYSE: CTLT), a leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. According to a recent article, “The agreement, which is scheduled to start this month, calls for the two companies to work together to potentially develop a novel, fast-acting therapy for treatment-resistant psychiatric…

Site Search

Company Search

Category: Stock Spotlight